(Reuters) - The cash offer of $50.25 per share by ReAble Therapeutics Inc. is about 20 percent more than DJO's Friday closing price of $42.10.
Read more at Reuters.com Mergers News
Read more at Reuters.com Mergers News
The Longs and the Shorts of my trading on the JSE. My thoughts, actions and rambelings while trading. The thing I love best!
No comments:
Post a Comment